Managing Pediatric Obesity Using Advanced Therapies 2023
DOI: 10.1007/978-3-031-37380-0_6
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacological Strategies for Pediatric Obesity

Claudia K. Fox,
Sarah J. Raatz,
Brooke R. Sweeney
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 81 publications
0
0
0
Order By: Relevance
“…Finally, while smaller, the STEP TEENS trial showed similar results for adolescents, prompting the US Food and Drug Administration last year to approve semaglutide for use in children 12 years and older . A recent Nature review argued that it’s the first medical intervention for pediatric obesity that not only results in weight loss but also improves cardiometabolic risk factors and quality of life …”
mentioning
confidence: 99%
“…Finally, while smaller, the STEP TEENS trial showed similar results for adolescents, prompting the US Food and Drug Administration last year to approve semaglutide for use in children 12 years and older . A recent Nature review argued that it’s the first medical intervention for pediatric obesity that not only results in weight loss but also improves cardiometabolic risk factors and quality of life …”
mentioning
confidence: 99%